VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
AMETEK, Inc. vs Becton, Dickinson and Company
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
AMETEK, Inc.
AME · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into AMETEK, Inc.'s moat claims, evidence, and risks.
View AME analysisBecton, Dickinson and Company
BDX · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Becton, Dickinson and Company's moat claims, evidence, and risks.
View BDX analysisComparison highlights
- Moat score: both at 66 / 100.
- Segment focus: AMETEK, Inc. has 2 segments (67.1% in Electronic Instruments Group (EIG)); Becton, Dickinson and Company has 5 segments (29.5% in Medical Essentials).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Strong vs Weak.
- Moat breadth: AMETEK, Inc. has 3 moat types across 1 domains; Becton, Dickinson and Company has 7 across 3.
Primary market context
AMETEK, Inc.
Electronic Instruments Group (EIG)
Advanced analytical, test and measurement instruments
Global
B2B (process, industrial, aerospace, medical, research)
Instrument/OEM supplier
67.1%
Becton, Dickinson and Company
Medical Essentials
Single-use medical consumables and specimen collection systems
Global
Healthcare providers and clinical labs
Manufacturer
29.5%
Side-by-side metrics
Moat coverage
Shared moat types
AMETEK, Inc. strengths
Becton, Dickinson and Company strengths
Segment mix
AMETEK, Inc. segments
Full profile >Electronic Instruments Group (EIG)
Oligopoly
Electromechanical Group (EMG)
Competitive
Becton, Dickinson and Company segments
Full profile >Medical Essentials
Competitive
Connected Care
Oligopoly
BioPharma Systems
Oligopoly
Interventional
Competitive
Life Sciences
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.